| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Jul 20, 2020 | Sale | $11.20 | 10,000 | 111,978 | 279,442 | Jul 22, 2020, 09:44 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Jun 22, 2020 | Sale | $14.93 | 47,210 | 704,921 | 298,047 | Jun 23, 2020, 06:58 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Jun 17, 2020 | Option Exercise | $14.91 | 536 | 7,989 | 274,710 | Jun 18, 2020, 09:45 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Jun 18, 2020 | Sale | $14.91 | 22,254 | 331,738 | 285,569 | Jun 18, 2020, 09:45 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Jun 15, 2020 | Sale | $13.33 | 20,000 | 266,627 | 284,442 | Jun 17, 2020, 05:14 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | May 20, 2020 | Sale | $12.40 | 2,802 | 34,755 | 275,843 | May 22, 2020, 06:55 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | May 21, 2020 | Sale | $12.41 | 7,198 | 89,323 | 278,041 | May 22, 2020, 06:55 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | May 06, 2020 | Option Exercise | $12.41 | 50,000 | 620,667 | 299,442 | May 20, 2020, 07:34 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | May 18, 2020 | Sale | $11.48 | 10,000 | 114,833 | 279,442 | May 20, 2020, 07:34 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | May 05, 2020 | Sale | $10.53 | 20,000 | 210,573 | 284,442 | May 20, 2020, 07:34 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Feb 12, 2020 | Sale | $11.77 | 66,976 | 788,566 | 289,936 | May 20, 2020, 07:33 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Feb 18, 2020 | Sale | $10.52 | 10,000 | 105,156 | 263,979 | Feb 20, 2020, 04:51 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Feb 12, 2020 | Sale | $11.77 | 66,945 | 788,215 | 289,967 | Feb 14, 2020, 08:57 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Feb 09, 2020 | Option Exercise | $10.24 | 15,494 | 158,659 | 274,473 | Feb 14, 2020, 08:55 PM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Feb 09, 2020 | Option Exercise | $10.24 | 11,551 | 118,282 | 309,867 | Feb 10, 2020, 07:57 AM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Feb 12, 2018 | Option Exercise | $6.85 | 10,806 | 74,021 | 248,367 | Feb 10, 2020, 07:52 AM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Apr 21, 2018 | Option Exercise | $6.30 | 605 | 3,812 | 247,762 | Feb 10, 2020, 07:52 AM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Feb 12, 2017 | Option Exercise | $3.00 | 12,793 | 38,379 | 276,742 | Feb 10, 2020, 07:52 AM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Feb 09, 2019 | Option Exercise | $3.33 | 12,599 | 41,955 | 332,659 | Feb 10, 2020, 07:52 AM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Apr 21, 2017 | Option Exercise | $2.70 | 657 | 1,774 | 276,085 | Feb 10, 2020, 07:52 AM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Feb 12, 2019 | Option Exercise | $3.55 | 10,652 | 37,815 | 322,007 | Feb 10, 2020, 07:52 AM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Aug 21, 2017 | Option Exercise | $2.50 | 5,479 | 13,698 | 270,606 | Feb 10, 2020, 07:52 AM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Apr 21, 2019 | Option Exercise | $5.98 | 589 | 3,522 | 321,418 | Feb 10, 2020, 07:52 AM | |
| ADVM | Adverum Biotechnologies, Inc. | Gasmi Mehdi | Director | Feb 09, 2018 | Option Exercise | $7.05 | 11,433 | 80,603 | 259,173 | Feb 10, 2020, 07:52 AM | |
| [AAVL] | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | SVP,Pharmaceutical Development | Jun 15, 2015 | Sale | $21.31 | 1,000 | 21,306 | 7,500 | Jun 17, 2015, 08:33 PM | |
| [AAVL] | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | VP, Pharmaceutical Development | Jun 08, 2015 | Option Exercise | $20.70 | 1,000 | 20,696 | 7,500 | Jun 10, 2015, 08:28 PM | |
| AAVL | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | VP, Pharmaceutical Development | May 28, 2015 | Option Exercise | $20.38 | 1,000 | 20,384 | 7,500 | Jun 05, 2015, 08:00 PM | |
| [AAVL] | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | VP, Pharmaceutical Development | May 28, 2015 | Option Exercise | $20.38 | 1,000 | 20,384 | 7,500 | May 29, 2015, 02:37 PM | |
| AAVL | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | VP, Pharmaceutical Development | May 21, 2015 | Option Exercise | $20.81 | 1,000 | 20,810 | 7,500 | May 22, 2015, 04:36 PM | |
| [AAVL] | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | VP, Pharmaceutical Development | May 14, 2015 | Option Exercise | $19.03 | 1,000 | 19,031 | 7,500 | May 15, 2015, 05:47 PM | |
| AAVL | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | VP, Pharmaceutical Development | May 07, 2015 | Sale | $18.01 | 1,000 | 18,013 | 7,500 | May 08, 2015, 07:09 PM | |
| AAVL | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | VP, Pharmaceutical Development | Apr 28, 2015 | Option Exercise | $19.21 | 2,000 | 38,417 | 8,000 | Apr 30, 2015, 06:51 PM | |
| AAVL | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | VP, Pharmaceutical Development | Apr 21, 2015 | Option Exercise | $20.98 | 2,000 | 41,961 | 1,000 | Apr 23, 2015, 04:58 PM | |
| AAVL | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | VP, Pharmaceutical Development | Apr 14, 2015 | Sale | $21.10 | 2,000 | 42,198 | 1,000 | Apr 15, 2015, 05:24 PM | |
| AAVL | Avalanche Biotechnologies, Inc. | Gasmi Mehdi | VP, Pharmaceutical Development | Apr 07, 2015 | Sale | $20.68 | 18,000 | 372,175 | 9,000 | Apr 08, 2015, 04:29 PM |
Menu